Bank of America’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.4M | Sell |
|
|||||
|
2025
Q2 | $25.5M | Buy |
|
|||||
|
2025
Q1 | $10.8M | Buy |
|
|||||
|
2024
Q4 | $6.77M | Sell |
|
|||||
|
2024
Q3 | $8.82M | Sell |
|
|||||
|
2024
Q2 | $8.04M | Sell |
|
|||||
|
2024
Q1 | $6.94M | Sell |
|
|||||
|
2023
Q4 | $8.51M | Buy |
|
|||||
|
2023
Q3 | $7.73M | Sell |
|
|||||
|
2023
Q2 | $9.56M | Sell |
|
|||||
|
2023
Q1 | $30.1M | Buy |
|
|||||
|
2022
Q4 | $11.3M | Buy |
|
|||||
|
2022
Q3 | $10.8M | Buy |
|
|||||
|
2022
Q2 | $8.07M | Buy |
|
|||||
|
2022
Q1 | $12M | Buy |
|
|||||
|
2021
Q4 | $4.94M | Sell |
|
|||||
|
2021
Q3 | $8.36M | Sell |
|
|||||
|
2021
Q2 | $15.3M | Sell |
|
|||||
|
2021
Q1 | $13.7M | Buy |
|
|||||
|
2020
Q4 | $5.41M | Sell |
|
|||||
|
2020
Q3 | $2.95M | Sell |
|
|||||
|
2020
Q2 | $8.54M | Buy |
|
|||||
|
2020
Q1 | $1.32M | Buy |
|
|||||
|
2019
Q4 | $1.3M | Buy |
|
|||||
|
2019
Q3 | $288K | Sell |
|
|||||
|
2019
Q2 | $1.6M | Buy |
|
|||||
|
2019
Q1 | $1.97M | Buy |
|
|||||
|
2018
Q4 | $347K | Buy |
|
|||||
|
2018
Q3 | $248K | Sell |
|
|||||
|
2018
Q2 | $666K | Buy |
|
|||||
|
2018
Q1 | $259K | Sell |
|
|||||
|
2017
Q4 | $289K | Buy |
|
|||||
|
2017
Q3 | $138K | Buy |
|
|||||
|
2017
Q2 | $89K | Sell |
|
|||||
|
2017
Q1 | $210K | Buy |
|
|||||
|
2016
Q4 | $111K | Buy |
|
|||||
|
2016
Q3 | $42K | Sell |
|
|||||
|
2016
Q2 | $45K | Buy |
|
|||||
|
2016
Q1 | $16K | Sell |
|
|||||
|
2015
Q4 | $232K | Sell |
|
|||||
|
2015
Q3 | $657K | Sell |
|
|||||
|
2015
Q2 | $1.36M | Buy |
|
|||||
|
2015
Q1 | $448K | Buy |
|
|||||
|
2014
Q4 | $595K | Buy |
|
|||||
|
2014
Q3 | $277K | Sell |
|
|||||
|
2014
Q2 | $1.19M | Buy |
|
|||||
|
2014
Q1 | $892K | Sell |
|
|||||
|
2013
Q4 | $726K | Buy |
|
|||||
|
2013
Q3 | $614K | Sell |
|
|||||
|
2013
Q2 | $281K | Buy |
|